193 related articles for article (PubMed ID: 15149655)
1. Synthesis and activity of phosphinic tripeptide inhibitors of cathepsin C.
Mucha A; Paweł M; Hurek J; Kafarski P
Bioorg Med Chem Lett; 2004 Jun; 14(12):3113-6. PubMed ID: 15149655
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
Ye Y; Liu M; Kao JL; Marshall GR
Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
[TBL] [Abstract][Full Text] [Related]
3. Pentapeptides containing two dehydrophenylalanine residues--synthesis, structural studies and evaluation of their activity towards cathepsin C.
Latajka R; Jewginski M; Makowski M; Pawełczak M; Huber T; Sewald N; Kafarski P
J Pept Sci; 2008 Oct; 14(10):1084-95. PubMed ID: 18523964
[TBL] [Abstract][Full Text] [Related]
4. Novel hydroxamic acid-related phosphinates: inhibition of neutral aminopeptidase N (APN).
Drag M; Grzywa R; Oleksyszyn J
Bioorg Med Chem Lett; 2007 Mar; 17(6):1516-9. PubMed ID: 17270439
[TBL] [Abstract][Full Text] [Related]
5. Diastereoselective solution and multipin-based combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitors.
Makaritis A; Georgiadis D; Dive V; Yiotakis A
Chemistry; 2003 May; 9(9):2079-94. PubMed ID: 12740857
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of p-aminophenyl aryl H-phosphinic acids and esters via cross-coupling reactions: elaboration to phosphinic acid pseudopeptide analogues of pteroyl glutamic acid and related antifolates.
Yang Y; Coward JK
J Org Chem; 2007 Jul; 72(15):5748-58. PubMed ID: 17602593
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitors; synthesis and activity of arecoline oxide tripeptide derivatives.
Marastoni M; McDonald J; Baldisserotto A; Canella A; De Risi C; Pollini GP; Tomatis R
Bioorg Med Chem Lett; 2004 Apr; 14(8):1965-8. PubMed ID: 15050638
[TBL] [Abstract][Full Text] [Related]
8. Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.
Vassiliou S; Mucha A; Cuniasse P; Georgiadis D; Lucet-Levannier K; Beau F; Kannan R; Murphy G; Knäuper V; Rio MC; Basset P; Yiotakis A; Dive V
J Med Chem; 1999 Jul; 42(14):2610-20. PubMed ID: 10411481
[TBL] [Abstract][Full Text] [Related]
9. An efficient route for the synthesis of glycosyl phosphinic acids.
Centrone CA; Lowary TL
J Org Chem; 2003 Oct; 68(21):8115-9. PubMed ID: 14535792
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
Matziari M; Bauer K; Dive V; Yiotakis A
J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
[TBL] [Abstract][Full Text] [Related]
11. Effect of epsilon-aminocaproylaminoacids on the activity of proteolytic enzymes.
Bruzgo I; Midura-Nowaczek K; Roszkowska-Jakimiec W; Jasielczuk J
Acta Pol Pharm; 2001; 58(2):137-40. PubMed ID: 11501792
[TBL] [Abstract][Full Text] [Related]
12. New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
Grzywa R; Sokol AM; Sieńczyk M; Radziszewicz M; Kościołek B; Carty MP; Oleksyszyn J
Bioorg Med Chem; 2010 Apr; 18(8):2930-6. PubMed ID: 20347318
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
Agamennone M; Campestre C; Preziuso S; Consalvi V; Crucianelli M; Mazza F; Politi V; Ragno R; Tortorella P; Gallina C
Eur J Med Chem; 2005 Mar; 40(3):271-9. PubMed ID: 15725496
[TBL] [Abstract][Full Text] [Related]
14. Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus.
Grobelny D; Wondrak EM; Galardy RE; Oroszlan S
Biochem Biophys Res Commun; 1990 Jun; 169(3):1111-6. PubMed ID: 2114105
[TBL] [Abstract][Full Text] [Related]
15. Conformational and solvation studies via computer simulation of the novel large scale diastereoselectively synthesized phosphinic MMP inhibitor RXP03 diluted in selected solvents.
Matziari M; Dellis D; Dive V; Yiotakis A; Samios J
J Phys Chem B; 2010 Jan; 114(1):421-8. PubMed ID: 20014753
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of α-carboxyphosphinopeptides derived from norleucine.
Pícha J; Buděšínský M; Fiedler P; Sanda M; Jiráček J
Amino Acids; 2010 Nov; 39(5):1265-80. PubMed ID: 20349321
[TBL] [Abstract][Full Text] [Related]
17. Efficient synthesis of Fmoc-protected phosphinic pseudodipeptides: Building blocks for the synthesis of matrix metalloproteinase inhibitors.
Bhowmick M; Sappidi RR; Fields GB; Lepore SD
Biopolymers; 2011; 96(1):1-3. PubMed ID: 20225219
[TBL] [Abstract][Full Text] [Related]
18. A silanediol inhibitor of the metalloprotease thermolysin: synthesis and comparison with a phosphinic acid inhibitor.
Kim J; Sieburth SM
J Org Chem; 2004 Apr; 69(9):3008-14. PubMed ID: 15104438
[TBL] [Abstract][Full Text] [Related]
19. Method for the synthesis of phosphinic acids from hypophosphites. V. The synthesis of pseudo-alpha,alpha-dipeptides.
Rozhko LF; Ragulin VV
Amino Acids; 2005 Aug; 29(2):139-43. PubMed ID: 15880266
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors.
Marastoni M; Baldisserotto A; Trapella C; Gavioli R; Tomatis R
Eur J Med Chem; 2006 Aug; 41(8):978-84. PubMed ID: 16713026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
